Partner With Us
The 9th Liquid Biopsy for Precision Oncology Summit provides an end-to-end perspective on liquid biopsy-enhanced drug trials, and is the ideal platform to showcase your solutions as we bring together the crème de la crème of liquid biopsy professionals. Our audience of over 250 decision-makers from leading biopharma are seeking to partner with companies with capabilities in assay development, diagnostics, AI, and bioinformatic solutions to help them drive precision oncology forward.
Present your cutting-edge technologies and services, take part in a panel discussion, exhibit your capabilities at a booth, or push the boat out and discuss bespoke partnership packages with unique deliverables to make your mark and stand out amongst your competitors.
Interested In Partnering?
I’m Sam, here to help and happy to set up a call so we can discuss your commercial objectives within the Liquid Biopsy for Precision Oncology space to establish whether partnering with this meeting aligns with your strategy.
Showcase your Pioneering Solutions
Present your cutting-edge technologies and diagnostic services to a focused audience of senior decision makers. With strategic exposure pre- and post-conference, differentiate your offerings from your competitors and seize branding opportunities to amplify your visibility and cement your position as a leader in advancing cancercare through precision medicine.
Gain Strategic Market Insights
Stay ahead in the evolving and competitive liquid biopsy landscape. Understand key priorities for biopharma and precision medicine leaders seeking innovative tools to improve MRD detection, real-time monitoring, and patient outcomes. Position your solutions to meet the latest regulatory demands and scientific standards in this critical field.
Forge High-Impact Collaborations
Engage with influential stakeholders from biopharma, diagnostics, and academic institutions within the liquid biopsy field. Dedicated intimate networking sessions, including speed networking and targeted discussions, foster unparalleled opportunities to create partnerships that drive progress in cancer diagnostics and patient care, with a shared goal of expanding precision oncology access.
Who Will You Meet?
